Coreg (carvedilol) for heart attack patients who have decreased heart function

July 2003

Glaxo is now promoting Coreg (carvedilol) for heart attack patients who have decreased heart function.

Coreg is the first beta-blocker APPROVED for reducing the risk of death in these patients.

Some reps will say it's better than the "old" beta-blockers... metoprolol, atenolol, propranolol, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote